Results 221 to 230 of about 1,140,223 (331)

A case report of metastatic renal cell carcinoma and ANCA associated vasculitis. [PDF]

BMC Nephrol
Taylor M, Rawlings C, Kan G, Mallett AJ, Harfield M.   +4 more
europepmc   +1 more source

RENAL CELL CARCINOMA WITH NON-SPECIFIC Ig-G ANTIBODY AND ITS TREATMENT

, 1985
Hideshi Miyakita, Yoshihiro Nagata, Hidechika Kinoshita, Nobuo Kawamura, Miho Hida   +4 more
openalex   +2 more sources

Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy

Aggregate, EarlyView.
Nanomaterial (NM)‐induced toxicity can be strategically repurposed for cancer therapy. This review summarizes the mechanism by which NMs selectively activate specific cellular processes to regulate cell fate independently. We also discussed how NMs‐induced biological responses can be leveraged as therapeutic strategies for cancer treatment.
Liting Wang, Hao Fu, Jiangtao Lin, Meng Zhao, Chuanrong Chen, Hongze Liao, Yourong Duan   +6 more
wiley   +1 more source

CLINICOPATHOLOGICAL OBSERVATION ON RENAL CELL CARCINOMA

, 1982
Fumio Yoneda, Go Akagi, Hisashi Otsuka
openalex   +2 more sources

Worth the Effort: Lessons for Discovery and Care From an Unusual Case of Gorlin Syndrome

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Gorlin‐Goltz Syndrome (GGS) is a rare autosomal dominant genetic disorder encompassing a diverse range of clinical manifestations, including congenital anomalies and predisposition to cancer. Pathogenic variants in PTCH1 and SUFU account for up to 79% and 6% of cases, respectively. Currently, an estimated 15%–27% of individuals with a clinical
V. Taliercio, J. Zhao, S. E. Boyden, R. Mao, P. Bayrak‐Toydemir, A. Pflaum, J. Palumbos, A. Andrews, E. E. Baldwin, C. Welt, Mackenzie Fait, Undiagnosed Diseases Network, L. D. Botto, D. Viskochil   +13 more
wiley   +1 more source

Chromophobe renal cell carcinoma with sarcomatoid change: A case report. [PDF]

Oncol Lett
Ahn AR, Noh SJ, Jeong YB, Kim KM.
europepmc   +1 more source

Animal models of lung cancer: Phenotypic comparison of different animal models of lung cancer and their application in the study of mechanisms

Animal Models and Experimental Medicine, EarlyView.
Grafts used to construct lung cancer animal models come from various sources, primarily cell lines, patient‐derived tumor tissues, and circulating tumor cells. Based on the sources of grafts and research objectives, lung cancer animal models can be categorized into several types: chemical‐induced models, orthotopic transplantation models, heterotopic ...
Zixuan Yang, Xianbin Zhao, Lili Tan, Pingxinyi Que, Tong Zhao, Wei Huang, Dejiao Yao, Songqi Tang   +7 more
wiley   +1 more source

Concomitant Wilms' tumor and renal cell carcinoma: Challenges in management and a case report. [PDF]

Int J Surg Case Rep
Mbwambo OJ, Yusuph M, Mwakipunda LE, Mbwambo J, Mremi A, Ngowi BN.   +5 more
europepmc   +1 more source

DEVELOPMENT OF A SERUM-FREE MEDIUM AND PRIMARY CULTURE OF HUMAN RENAL CELL CARCINOMAS BY SERUM-FREE CULTURE

, 1989
Haruo Itô, Kunio Yamaguchi, T Kotake, Osamu Matsuzaki   +3 more
openalex   +2 more sources

A hepatoprotective experiment on taro vegetable (Colocasia esculenta (L.) Schott) flower employing animal models by mitigating oxidative stress

Animal Models and Experimental Medicine, EarlyView.
The antioxidant efficacy of Colocasia esculenta flower’s methanolic extract was assessed using 2,2′‐azino‐bis‐(3‐ethylbenzothiazoline‐6‐sulfonic) (ABTS) and 2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) scavenging assay. The hepatoprotective effect was investigated by assessing liver injury indicators (amino transferase [ALT], aspartate amino transferase [AST],
Mahathir Mohammad, Fahmida Tasnim Richi, Rabiul Hossain, Md. Arafat, Pair Ahmed Jiko, Nazim Uddin Emon, Sayed Al Hossain Rabbi, Tirtha Khastagir, Md. Hemayet Hossain, Safaet Alam   +9 more
wiley   +1 more source